A Prospective Study of the Bard® LifeStent® Solo Vascular Stent System

NCT02262949 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

C. R. Bard